SYNOPSIS A macroscopic agglutination test for detecting leptospiral antibodies in human sera is described. The test utilizes a stained preparation of non-pathogenic leptospires and is performed on the Brewer diagnostic cards used for bovine brucellosis screening. The agglutination of the stained antigen is more easily observed than the current macroscopic slide test using unstained leptospiral antigens. The non-pathogenic serotype patoc is agglutinated by sera from humans infected with serotypes pomona, hardjo, ballum, and copenhageni with a sensitivity of 94 % in comparison with the microscopic agglutination test.
SYNOPSIS A macroscopic agglutination test for detecting leptospiral antibodies in human sera is described. The test utilizes a stained preparation of non-pathogenic leptospires and is performed on the Brewer diagnostic cards used for bovine brucellosis screening. The agglutination of the stained antigen is more easily observed than the current macroscopic slide test using unstained leptospiral antigens. The non-pathogenic serotype patoc is agglutinated by sera from humans infected with serotypes pomona, hardjo, ballum, and copenhageni with a sensitivity of 94 % in com- parison with the microscopic agglutination test.
The laboratory diagnosis of recent leptospiral infections in man may be established either by isolating the infecting organism or by demonstrating a rise in the specific antibody titre. The isolation of the organism has been shown to be feasible, at least for the New Zealand serotypes (Christmas et al, 1974) , and is of undoubted epidemiological importance. However, the time taken to culture and identify the organism allows confirmation of the diagnosis in retrospect only. For the detection of specific antibodies the microscopic agglutination test (MAT) (World Health Organization, 1967) is still the standard reference test for leptospiral diagnosis.
However, the disadvantages of maintaining a battery of live cultures for the performance of the MAT are well known.
A large number of preliminary tests using genus specific antigens or pools of antigens have been developed. Those involving agglutination of the nonpathogenic serotype patoc (Combiescu et al, 1958) , haemagglutination (Palit and Gulasekharam, 1973; Sulzer and Jones, 1973) , haemagglutination-lysis , complement fixation (Elian and Nicoara, 1964; Turner, 1968) , and immunofluorescence (Torten et al, 1966) all require specialized equipment, and some involve the growth of large volumes of leptospires for the extraction of antigen.
A simple macroscopic slide test reported by Galton et al (1958) is the basis of the commercial screening antigens2 which are used by some local laboratories in New Zealand. This report describes an improvement of this test and the use of a single non-pathogenic (serotype patoc) antigen as a screening test for human leptospirosis. (Wolff, 1954) . Immune rabbit sera were prepared in New Zealand White rabbits by giving an intramuscular injection of the leptospires centrifuged from approximately 20 ml of culture, and emulsified in 2 ml of a mixture of equal parts of saline and incomplete Freund's adjuvant. When necessary, booster injections of 5 ml of culture were given intraperitoneally to obtain homologous MAT titres HUMAN 
Material and Methods

ORGANISMS
SERA
Human sera were obtained from culturally proven cases of leptospirosis either in New Zealand, or in Denmark in the case of copenhageni, or were selected at random from specimens received for leptospiral serology at the National Health Institute.
ANTIGEN PREPARATION
Leptospires were grown in 50 ml volumes of medium. Well-grown cultures were killed by the addition of 1:10 000 thiomersal (Merthiolate, Lilly), centrifuged, washed twice in normal saline, and resuspended in 1 % (w/v) Ponceau S in 0-O1M phosphate buffered saline, pH 7*3 (PBS). After standing overnight at 5°C leptospires were washed in PBS until the supernatant was colourless. The staining procedure was repeated when necessary to produce a deep red-brown stained antigen. Stained leptospires were resuspended in PBS to a concentration of 5% (v/v) test antigen positive) of 45 % and a type II error (false negative) of 5-6%. The sensitivity, therefore, is 94%, and if In the two cases where the MAT titre was 400 the the three cases where the sera were taken in the later card test was positive for the next serial specimen stages of the infection can be discounted, the sensitaken three to four weeks later. In the other three tivity is better than 96%. The specificity is 55 %. cases, subsequent sera taken four to five weeks later were negative in the MAT, indicating that the sera Discussion giving the anomalous results were taken in the later stages of the infection. (Palit and Sharma, 1971; Robertson and Boulanger, 1963) , haemagglutination tests (Palit and Sha-rma, 1971 ), haemagglutination-lysis tests (Cox, 1955) , and in the macroscopic slide test (Galton et al, 1958) , while bovine sera show very little cross-reactivity. Cross reactions have been observed in most leptospiral serological tests when human sera have been examined, the frequent reaction with serotype patoc leading to the development of many genus-specific antigens (Combiescu et al, 1958; Cox, 1957; Elian and Nicoaia, 1964; Palit and Gulasekharam, 1973) .
Our results show that in the card test human sera agglutinate the patoc antigen more strongly than they agglutinate a pool of antigens containing the infecting strain. The cross-reactions of the human sera were the same as those of the rabbit immune sera but with a much lower degree of agglutination. The card test is therefore of little value for determining the infecting serotype and there is no advantage in using either pools of pathogenic leptospires or individual antigens. Since the treatment for leptospirosis is not in general influenced by the infecting serotype, a rapid diagnosis of leptospirosis using a genus-specific antigen is adequate.
The patoc card test compares favourably in sensitivity to the MAT. Provided the serum was taken at least 8-10 days after the onset of illness a negative card test can reasonably be taken to preclude a diagnosis of leptospirosis. While the specificity is rather low this is not a disadvantage in a preliminary test as all reactive sera should be referred for MAT titres. The false positives could be either sera taken early in the infection before the MAT has risen to 1 :100 or a reflection of natural antibody (Faine and Carter, 1968) . A preliminary study of 'normal' human sera indicates a high incidence of low levels of antibody to patoc; however, these reactions are eliminated by diluting the serum 8-10 fold before testing in the card test. It is suggested, therefore, that all sera are tested undiluted, and that those that are reactive are re-tested in serial dilutions. As with the MAT, it is still necessary to demonstrate a rise in antibody titre in two serial specimens in order to confirm a diagnosis of leptospirosis.
The patoc antigen has the advantage of being nonpathogenic and more easily and cheaply grown than pathogenic strains, and it may detect antibodies to previously unsuspected strains. The (Joint FAO/WHO, 1971; Pilet et al, 1972) and for syphilis (World Health Organization, 1970) are well established and have been used satisfactorily for many years.
